compared to petroleum-based astaxanthin. Animal feed is the primary market which thrives on
synthetic astaxanthin from petroleum, whereas human nutrition is majorly driven by natural
astaxanthin. However, the demand for natural astaxanthin in animal nutrition has been increasing in
recent years due to a number of safety issues associated with the consumption of animal meat treated
with petroleum-based astaxanthin. Among other sources, plants are the fastest-growing segment, by
source.
“Asia-Pacific: The largest astaxanthin market”
The Asia-Pacific region was the largest regional market for astaxanthin in 2016. The growing
awareness of the importance of antioxidants such as astaxanthin in the human diet, the high
consumption of astaxanthin from the aquafeed industry, and increasing demand for antioxidants from
food and supplement industries, contribute to the significant share of the Asia-Pacific region in the
global astaxanthin market. Major markets in the Asia-Pacific region include China, India, and
Australia-New Zealand.
Break-up of Primaries:
? By Company Type – Tier 1- 40%, Tier 2- 40%, Tier 3- 20%
? By Designation – C level-20%, Directors-40%, Others- 40%
? By Region – North America-25%, Europe-50%, and Asia-Pacific- 25%
Leading players profiled in this report are as follows:
• Koninklijke DSM N.V. (Netherlands)
• BASF SE (Germany)
• Cyanotech Corporation (U.S.)
• Otsuka Pharmaceuticals Co., Ltd. (Japan)
• Valensa International (U.S.)
• Fuji Chemical Industries CO., Ltd. (Japan)
• Divis Laboratories Ltd. (India)
• Beijing Ginko Group (China)
• Igene Biotechnology, Inc. (U.S.)
• Piveg, Inc. (U.S.)
• Fenchem Biotek, Ltd. (U.S.)